Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Geely Emerges as China’s Silent Contender in the EV Race

Robert Sasse by Robert Sasse
August 18, 2025
in Stocks
0
Geely Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

While Tesla and BYD dominate electric vehicle headlines, China’s Geely has been quietly assembling a formidable global presence in the sector. Through strategic market positioning, technological advancements, and an expanding vehicle lineup, the automaker appears poised to challenge industry leaders.

Financial Strength and Market Position

Market analysts remain bullish on Geely’s prospects. BOCI Securities recently increased its price target for the company from $29 to $32 while maintaining its "buy" recommendation. This confidence stems from two key factors:

  • Resilient Financial Performance: Despite a modest decline in core profits to 3.2 billion yuan in Q2 2025, the company maintained profitability with a 7.3% quarter-over-quarter revenue increase.
  • Expanding Market Share: Geely now commands 6.4% of the global new energy vehicle (NEV) market, securing third place behind BYD (18.3%) and Tesla (11.7%).

Dual-Pronged Market Strategy

Geely’s approach combines accessibility with innovation:

  1. Affordable Urban Mobility: Through its Livan sub-brand, the company introduced the "Smurf" – a compact EV priced below $5,000, designed specifically for city dwellers.
  2. Technological Innovation: The Australian launch of the Starray EM-i marks the debut of the world’s first hybrid SUV featuring Geely’s EM-i Super Hybrid System. Simultaneously, existing models are receiving Apple CarPlay integration via over-the-air updates.

The company is also making inroads in untapped markets, pioneering electric pickup trucks in Pakistan with its Riddara model.

Should investors sell immediately? Or is it worth buying Geely?

Operational Excellence and Innovation

Behind the scenes, Geely demonstrates remarkable manufacturing capabilities:

  • Its Guiyang facility delivered more than 10,000 Galaxy E5 electric SUVs within just 20 days.
  • The ShenDun battery, developed in-house, achieved production readiness in a record-breaking 10 months.

Investor confidence appears strong, with a recent block trade of 500,000 shares at HK$19.78. Though currently trading about 6% below its yearly peak, the stock maintains a positive technical outlook.

The Road Ahead

As industry attention remains fixed on market leaders, Geely’s balanced strategy of mass-market appeal and technological advancement positions it as a potential dark horse in the EV sector. The company’s next quarterly results will reveal whether its upward trajectory can be sustained.

Ad

Geely Stock: Buy or Sell?! New Geely Analysis from February 7 delivers the answer:

The latest Geely figures speak for themselves: Urgent action needed for Geely investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Geely: Buy or sell? Read more here...

Tags: Geely
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Siemens Healthineers Stock

Could Siemens Healthineers Emerge as the Dark Horse of Medical AI Innovation?

Assembly Biosciences Stock

Biotech Stock Assembly Biosciences Gains Analyst Backing with $50 Price Target

Synopsys Stock

Synopsys Stock: Diverging Signals Between Executives and Analysts

Recommended

Fiserv Stock

Fiserv Shares Struggle to Gain Traction Amid Investor Doubts

3 weeks ago
Cooper-Standard Stock

Cooper-Standard Shares Plunge on Disappointing Earnings Report

3 months ago
Volatus Aerospace Stock

Volatus Aerospace Expands Defense and Environmental Technology Operations

5 months ago
FCBC stock news

Symmetry Partners LLC Acquires Significant Position in Carnival Co. & plc, Expresses Optimism for Future Growth

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Trending

Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

by Rodolfo Hanigan
February 7, 2026
0

Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday,...

Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com